Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers

Clinical and Experimental Dermatology

Volumn 35, Issue 8, 2010, Pages 885-887

  Ferri, C ^a   Giuggioli, D ^a   Manfredi, A ^a   Quirici, N ^b   Scavullo, C ^b   Colaci, M ^a   Gianelli, U ^c   Lambertenghi Deliliers, G ^d   Del Papa, N ^e  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Department of Medicine Surgery and Dental Sciences   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE MARROW; CASE REPORT; DRUG DOSE REDUCTION; DRUG SAFETY; ENDOTHELIUM CELL; EPITHELIZATION; GRANULATION TISSUE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCLERODERMA; SKIN ULCER; SYSTEMIC SCLEROSIS; ULCER HEALING; WOUND HEALING IMPAIRMENT;

AGED; APOPTOSIS; BONE MARROW; ENDOTHELIAL CELLS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; SCLERODERMA, SYSTEMIC; SKIN ULCER; WOUND HEALING;

EID: 78149362868     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03847.x     Document Type: Article

References (10)

1. Kuwana M, Okazaki Y, Yasouka H et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603-10.
2. Ferri C, Giuggioli D, Sebastiani M, Colaci M. Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol 2007; 32: 287-90.
3. Del Papa N, Quirici N, Soligo D et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54: 2605-15.
4. Thiele J, Kvasnicka HM, Facchetti F et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128-32.
5. LeRoy EC. Systemic sclerosis: a vascular perspective. Rheum Dis Clin North Am 1996; 22: 675-94.
6. Lunardi C, Bason C, Navone R et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6: 1183-6.
7. Ferri C, Zakrzewska K, Longombardo G et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999; 17: 718-20.
8. Fliser D, Bahlmann FH. Erythropoietin and the endothelium - a promising link? Eur J Clin Invest 2008; 38: 457-61.
9. Paschos N, Lykissas MG, Beris A. The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci 2008; 4: 161-8.
10. Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008; 141: 14-31.